Tms

4891.TTSE GROWTHPharmaceutical
Filed as TMS Co.,Ltd. (2023-01–2023-01), TMS Co., Ltd. (2023-05–2026-08)
Major holders (5%+) · 0
HolderStakeChangeFiled

No holder currently reports 5% or more.

Each holder's own ratio from its most recent large-shareholding report.

Former and minor holders (below 5%) · 6
-4.59%2025-01-30
Growth Capital Inc.4.36%2026-08-14
TOHOKU University Venture Partners3.85%2026-11-04
NISSAY CAPITAL CO., LTD3.66%2025-02-07
-0.08%2024-11-08
RTW Investments, LP0.00%2025-09-11
Ownership history · 31
FiledHolderRatioChangePurpose
2024-11-08-2024-11-085.80%-0.91ppPure investment
2024-07-23-2024-07-230.14%+0.03pp—
2024-07-23-2024-07-236.71%-0.24ppPure investment
2024-07-11-2024-07-110.11%-0.04pp—
2024-07-11-2024-07-116.95%-2.05ppPure investment
2024-06-12-2024-06-120.15%new—
2024-06-12-2024-06-129.00%newPure investment
2024-04-05AmendedNISSAY CAPITAL CO., LTD2024-04-05 · amended7.29%-1.15pp—
2024-03-07AmendedNISSAY CAPITAL CO., LTD2024-03-07 · amended8.44%-1.31pp—
2024-02-08AmendedNISSAY CAPITAL CO., LTD2024-02-08 · amended9.75%new—
2024-02-05AmendedRTW Investments, LP2024-02-05 · amended0.00%new—

Each holder in 5% reports, joint holders included. Purpose is classified from the filed text.